학술논문

FBXO44 promotes DNA replication-coupled repetitive element silencing in cancer cells
Document Type
article
Source
Cell. 184(2)
Subject
Biomedical and Clinical Sciences
Oncology and Carcinogenesis
Immunology
Cancer
Immunotherapy
Human Genome
Genetics
2.1 Biological and endogenous factors
1.1 Normal biological development and functioning
Adult
Cell Line
Tumor
Cell Proliferation
Cell Survival
DNA Breaks
Double-Stranded
DNA Replication
Drug Resistance
Neoplasm
F-Box Proteins
Female
Gene Expression Regulation
Neoplastic
Histones
Humans
Immune Checkpoint Inhibitors
Immunity
Interferons
Lysine
Male
Methylation
Middle Aged
Neoplasm Proteins
Neoplasms
Nucleosomes
Repetitive Sequences
Nucleic Acid
Signal Transduction
Transcription
Genetic
Treatment Outcome
FBXO44
H3K9me3
SUV39H1
immunotherapy
repetitive elements
Biological Sciences
Medical and Health Sciences
Developmental Biology
Biological sciences
Biomedical and clinical sciences
Language
Abstract
Repetitive elements (REs) compose ∼50% of the human genome and are normally transcriptionally silenced, although the mechanism has remained elusive. Through an RNAi screen, we identified FBXO44 as an essential repressor of REs in cancer cells. FBXO44 bound H3K9me3-modified nucleosomes at the replication fork and recruited SUV39H1, CRL4, and Mi-2/NuRD to transcriptionally silence REs post-DNA replication. FBXO44/SUV39H1 inhibition reactivated REs, leading to DNA replication stress and stimulation of MAVS/STING antiviral pathways and interferon (IFN) signaling in cancer cells to promote decreased tumorigenicity, increased immunogenicity, and enhanced immunotherapy response. FBXO44 expression inversely correlated with replication stress, antiviral pathways, IFN signaling, and cytotoxic T cell infiltration in human cancers, while a FBXO44-immune gene signature correlated with improved immunotherapy response in cancer patients. FBXO44/SUV39H1 were dispensable in normal cells. Collectively, FBXO44/SUV39H1 are crucial repressors of RE transcription, and their inhibition selectively induces DNA replication stress and viral mimicry in cancer cells.